| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |